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Abstract
Aims: Myeloblastosis Associated Virus type 1 (N) [MAV 1(N)] induces specifically nephroblastomas in 8–10
weeks when injected to newborn chicken. The MAV-induced nephroblastomas constitute a unique animal model
of the pediatric Wilms' tumor. We have made use of three independent nephroblastomas that represent
increasing tumor grades, to identify the host DNA regions in which MAV proviral sequences were integrated.
METHODS Cellular sequences localized next to MAV-integration sites in the tumor DNAs were used to screen
a Bacterial Artificial Chromosomes (BACs) library and isolate BACs containing about 150 kilobases of normal
DNA corresponding to MAV integration regions (MIRs). These BACs were mapped on the chicken chromosomes
by Fluorescent In Situ Hybridization (FISH) and used for molecular studies.
Results: The different MAV integration sites that were conserved after tumor cell selection identify genes
involved in the control of cell signaling and proliferation. Syntenic fragments in human DNA contain genes whose
products have been involved in normal and pathological kidney development, and several oncogenes responsible
for tumorigenesis in human.
Conclusion: The identification of putative target genes for MAV provides important clues for the understanding
of the MAV pathogenic potential. These studies identified ADAMTS1 as a gene upregulated in MAV-induced
nephroblastoma and established that ccn3/nov is not a preferential site of integration for MAV as previously
thought. The present results support our hypothesis that the highly efficient and specific MAV-induced
tumorigenesis results from the alteration of multiple target genes in differentiating blastemal cells, some of which
are required for the progression to highly aggressive stages. This study reinforces our previous conclusions that
the MAV-induced nephroblastoma constitutes an excellent model in which to characterize new potential
oncogenes and tumor suppressors involved in the establishment and maintenance of tumors.
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Introduction
Chicken nephroblastomas induced by MAV1-N represent
a unique animal model of the Wilms tumor, a kidney can-
cer occurring in young children at a frequency of about
1:6000 births. Early cytogenetic studies have identified
multiple chromosomal alterations in Wilms tumors, rais-
ing the possibility that several steps in the differentiation
pathway of blastemal cells could represent potential tar-
gets for tumorigenic events [1].
In an attempt to characterize genes that are altered at var-
ious stages of tumor development, we have taken advan-
tage of the histological similarities between Wilms tumor
and MAV-1(N) induced nephroblastoma.
MAV is a replication competent retrovirus which can
induce nephroblastomas, osteopetrosis and lymphoid
leucosis when injected in chicken [2]. Molecular cloning
of the MAV1(N) proviral genome permitted us to isolate
a pure viral strain inducing specifically nephroblastomas
when injected, either intravenously in ovo on embryonic
day 18, or intraperitoneally in day-old chickens [3]. The
characterization of MAV sequences contained in avian
nephroblastomas established that these tumors were pol-
yclonal and that in tumor DNA, MAV was inserted at a
limited number of sites, suggesting that either the integra-
tion of MAV at other sites was not associated with neph-
roblastoma induction, or that the selection pressure
occuring naturally during tumor development had coun-
terselected cells carrying MAV proviral genomes at other
sites [1,4].
The analysis of lambda librairies obtained from these
tumors reinforced the idea that in the tumor DNA, the
MAV proviral sequences were integrated at a few distinct
cellular sites. The MAV genomes present in well-devel-
oped tumors were all heavily rearranged whereas in dif-
fuse tumors of smaller size showing a less advanced tumor
phenotype, the MAV genomes were full length in size and
functional [5].
Use of junction fragments containing viral U3 and adja-
cent cellular sequences, permitted to establish that in one
of the most developed tumor one of the proviral genome
was integrated within a gene that is known as ccn3 and
that we originally designated "nov" for « nephroblastoma
overexpressed » [5].
CCN3 is one of the three founders of the CCN family of
proteins which presently consists of six different mem-
bers. Its expression is associated with cell quiescence [6,7].
In normal conditions, the expression of ccn3 undergoes
spatiotemporal regulation in several different tissues orig-
inating from the three germ layers, with major sites of
expression being adrenal, nervous system, cartilage and
bone, muscle, and kidney [7-14]. The production of
CCN3 protein can be increased or decreased upon car-
cinogenesis [7,12,15-20]. In Wilms' tumors, the expres-
sion of ccn3 was a marker of differentiation [12] whereas
in Ewings' tumors, the expression of ccn3 was associated
with a higher risk of developing metastasis [17]. In all
cases, the full length CCN3 protein shows antiprolifera-
tive activity.
Albeit its expression was elevated in all avian tumors, the
ccn3 gene was found to be disrupted in only one case, sug-
gesting that either an unknown viral product, or MAV LTR
enhancer was responsible for increased ccn3 expression.
Indeed, it is well known that LTR enhancer sequences can
activate transcription of genes localized several tens of
kilobases away. However, the limited size (20 kb) of the
insert DNA that was contained in the lambda recom-
binants, did not permit to establish whether MAV LTR
sequences were present in the vicinity (at a genome scale)
of the ccn3 gene in the DNA of all tumor cells.
Since we had isolated and studied tumors representing
three increasing developmental stages, we took advantage
of this material to ask whether the progression from an
initial diffuse tumor to a well developed tumor, was
accompanied by the selection of cells carrying particular
MAV integration sites. To tackle this problem, we have
used the BAC (bacterial artificial chromosome) and FISH
(fluorescent in situ hybridization) strategies.
The results we report here confirm that a limited number
of MAV-integration sites are detected in the DNA of MAV-
induced nephroblastomas, with an over representation of
integration sites on chromosome 2. In well-developed
tumors, MAV-integration sites are localized in the vicinity
of genes encoding proteins involved in matrix remode-
ling, angiogenesis, and signaling. Our results also indi-
cated that ccn3 is not a common integration site in these
tumors.
Materials and methods
Labeling of the BAC DNA fragments
Prior to labelling, the BAC DNA fragments were amplified
by PCR using the Expand high fidelity PCR system from
BOEHRINGER MANNHEIM. One hundred nanograms of
insert was mixed with U and R primers (0.3 µM/L), 8 µl
dNTP(10 mM), mix II buffer (10 µl), TaqE (3 U) and
water to 50 µl. Amplification was performed for 30 cycles
of 94°C for 30 seconds, 50°C for 1 min, 72°C for 1 min.
The size of the amplified fragments were checked by elec-
trophoresis in 1% agarose gels prior to purification with
the QIAquick PCR Purification Kit (Qiagen). DNA frag-
ments (50 ng of each) were labeled with the Amersham
multiprime DNA labelling system (Amersham Pharmacia
Biotech RPN161Z LIFE SCIENCE) in the conditions rec-
Cell Communication and Signaling 2006, 4:1 http://www.biosignaling.com/content/4/1/1
Page 3 of 15
(page number not for citation purposes)
ommended by the supplier and purified by filtration
through Sephadex G50 to remove nucleotides that were
not incorporated.
Screening of the BAC library
Duplicate filters on which BAC DNA preparations had
been transfered were incubated with labelled probes as
described above. Colonies containing positive BACs were
picked and grown at 37°C overnight into 4 µ of LB
medium containing 10 µg/ml chloramphenicol. The DNA
contained in pelleted cells was extracted as described
above and resuspended in 40 µl of TE containing RNaseA.
The DNA content of each BAC was analyzed by both Dot
blotting and Southern blotting of HindIII-digested DNA.
Ccn3 probe
The pC1K clone [5] was used as a source of chicken ccn3.
For preparation of the ccn3 probe, the 2.0 kb
Kpn1fragment was purified by electroelution as described
[21]
Isolation and characterization of BACSFigure 1
Isolation and characterization of BACS. Panel A shows typical results obtained with a BAC containing a MAV-integration site 
contained in one of the probes dereived from avian nephroblastoma. Filters of BAC DNA were duplicated. To check the spe-
cificity of the probes used, two micrograms of genomic chicken DNA were digested with 40 units of HindIII restriction endo-
nuclease at 37°C for 18 hours and run in a 1% agarose gel at 2 volts/cm for 20 hours. The separated DNA fragments were 
denatured by incubation in 0.5 N NaOH for 45 min, neutralized in 0.5 M Tris HCl, 1.5 M NaCl. Transfer onto Appligene Posi-
tive Membrane was performed in 20 × SSC for 18 hours and the membrane was baked for 2 hours at 80°C prior to use for 
hybridization with labeled cloned cellular fragments. All cellular probes cloned from nephroblastoma DNA libraries detected a 
single fragment in HinIII digested normal DNA (see panel C for typical result) except for P38 which contained chicken repeti-
tive sequences (panel B). Panels D and E: DNA preparations from positive Bacs were digested with NotI (panel 1 E shows 
ethidium bromide staining of the gel) and transfered onto nitrocellulose prior to hybridization with the probes used for their 
isolation. A single NotI fragment is detected by the probes in the BAC dans (panel 1D).
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Listing of positive BACsFigure 2
Listing of positive BACs. All positive BACs are listed with the origin of the probes used for their isolation. The three groups 
corrrespond to tumors representing increasing developmental stages.
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Isolation of polyadenylated RNA from normal kidneys and 
nephroblastomas
Frozen tissues were homogenized with a polytron and 0.5
g of powder was resuspended in 9 ml guanidine thiocy-
anate buffer for purification of total RNA as previously
described [21]. Final RNA pellets were resuspended in 400µl sterile distilled water and the concentration of each
sample was determined by densitometry. To isolate poly-
adenylated RNA species, each sample (1 mg total RNA in
500 µl water) was mixed with 55 µl Oligitex Suspension
(Qiagen) and incubated for 3 min at 70 min in a water
bath. After 10 min at room temperature the Oligo-
tex:mRNA complex was pelleted by 2 min centrifugation
at 14000–18000 g and the supernatant carefully removed.
The pellet was further treated as recommended by the sup-
plier and the polyadenylated RNA fraction was collected
in a final volume of 50 µl.
Labelling of polyadenylated RNA preparations
To prepare labelled RNA probes, 500 ng of each polyA-
RNA preparation were mixed with 500 ng oligo dT, incu-
bated for 10 min at 70°C and chilled on ice for 5 min.
Samples were then mixed with 5 µl of 10 × PCR buffer, 5µl of MgCl2 25 mM, 5 µl DTT 0.1 M, 2.5 µl mixture of
dTTP, dATP, dGTP(10 mM each), 2.5 µl of ddTTP(1 mM),
5 µl of 32P-dCTP, and incubated for 5 min at 25°C. After
addition of 1 µl of reverse transcriptase (Invitrogen) (200
U/ µl), the mix was incubated for 10 more min at 25°C
and for 50 min at 42°C. The reaction was stoped by incu-
bation at 70°C for 15 min. Each labelled preparation was
purified by chromatography through a column of Sepha-
dex G50.
Hybridization of BAC DNA filters
The blots were rinsed with 6 × SSC, and prehybridized at
68°C for 18 hours. After hybridization with labeled probe
in the presence of COT I DNA the blots were washed with
2 × SSC, 0.1%SDS at 56°C for 1 hour and with: 0.1 × SSC,
0.1%SDS at 65°C for 1 more hour. Autoradiography of
the dried blot was performed at -80°C.
Distribution of positive BACs on chicken chromosomesFigure 3
Distribution of positive BACs on chicken chromosomes.
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Purification of BAC DNA fragments
To recover the DNA fragments containing sequences that
encode differentially expressed RNAs, 4 µg of BAC DNA
were digested with HindIII, and run in 1% low melting
agarose gel. The fragments of interest were eluted by incu-
bation at 65°C for 10 min prior to addition of 1 ml Wiz-
ard Plus resin from Promega and filtration through a
minicolumn connected to vacuum manifold. The column
was rinsed with washing buffer and the DNA fragments
eluted with 50 µl of TE buffer.
Ligation and transformation
HindIII digested purified DNA fragment (50–100 ng)
were ligated to 50 ng of dephosphorylated HindIII-
digested pUC18 vector in the presence of 2.5 µl T4 ligase
(Appligene) at 14°C for 18 hours. For transformation, 2µl samples of the ligation mixture were mixed with 200 µl
of DH5α competent cell. Electroporation was performed
at 2.45 Kv, 25 µF, 400 Ohm. After addition of 1 ml of cold
LB medium, bacteria were spread onto LB plate contain-
ing 100 µg/ml ampicillin and incubated at 37°C.
Screening of chicken cDNA libraries
A library of chicken spleen cDNA was spread on LB agar
plates containing tetracycline(7.5 µg/ml) and ampi-
ciline(12.5 µg/ml) and incubated at 37°C, overnight. The
colonies were transferred to Qbiogene Neutral Mem-
branes and replicated to LB agar plates containing tetracy-
cline and ampiciline. The membranes were incubated
successively in 0.5 N NaOH for 10 min, 0.2 N NaOH and
1.5 M NaCl for 10 min, 0.2 M TrisHCl and 2 mM EDTA
for 20 seconds and 2 × SSC for 20 seconds. The filters were
baked at 80°C for 2 hours prior to use for hybridization
with appropriate probes.
Sequencing of positive cDNA clones
Sequencing of the cDNAs was performed with T7 univer-
sal primer and CDM8 (TAAGGTTCCTTCACAAA) primer.
Northern blot hybridization
Samples of total RNA (20 µg in 9.3 µl water) were incu-
bated with, 20 µl deionized formamide, 6.7 µl formalde-
hyde, 4 µl 10 × MOPS, incubated for 5 min at 68°C,
chilled on ice before loading. Formaldehyde-MOPS gels
were run at 100 volts for loading and 50 volts overnight in
1 × MOPS buffer. The gel were then rinsed with DEPC-
treated 20 × SSC containing 2 mercaptoethanol, trans-
ferred to Appligene positive Membranes and treated for
hybridization.
Prehybridization was performed in 50% formamide, 5 ×
SSC, 3 x Denhardt, 0.5% SDS, 0.05 M NaH2PO4, salmon
sperm DNA 100 µg/ml, at 42°C for 3 hours. Hybridiza-
tion was performed in the same solution containing
probes(1–3,000,000 cpm/ml). Washing of the membrane
was performed in 2 × SSC, 0.2% SDS.
Cultures and chromosome preparation
Chicken (Gallus gallus) cells were obtained from 9-days-
old embryos using trypsin. The cultures were incubated at
37°C or 41°C in MEM medium supplemented with 20%
foetal calf serum, glutamine and penicillin/streptavidin.
For cytogenetic preparations, the cells were collected using
trypsin and treated with an hypotonic solution: KCL (2.8
g/l), foetal calf serum 1/12 and they were fixed with 3:1
methanol/glacial acetic acid. The same procedure was
used for the other galliformes tested namely: the Com-
mon Quail (Coturnix coturnix), the Red-legged Partridge
(Alectoris rufa), the Grey Peacock-Pheasant (Polyplectron
bicalcaratum), the Cheer Pheasant (Catreus wallichi), the
Common Pheasant, (Phasianus colchicus), the grey par-
tidge (Perdix perdix), the turkey (Meleagris gallopavos) and
the guinea-fowl (Numida melagris).
Fluorescent in situ hybridization (FISH)
The purified DNA inserts were labelled by nick translation
with biotin or digoxigenin 16 dUTP (Appligene OncorR
Mapping of BAC sequences on chicken chromosome 2Figure 5
Mapping of BAC sequences on chicken chromosome 2.
Mapping of BAC sequences on chicken chromosome 1Figure 4
Mapping of BAC sequences on chicken chromosome 1.
Cell Communication and Signaling 2006, 4:1 http://www.biosignaling.com/content/4/1/1
Page 7 of 15
(page number not for citation purposes)
nick-translation kit, Illkirch Graffenstaden, France)
according to manufacturer's instructions.
Chromosomes slides were incubated at 70°C for 2 min in
70% formamide, 2 × SSC (pH 7.2) and dehydrated in an
ethanol series at 4°C. 2 µl of a 1/5 dilution of labelled
probe was mixed with 6 µl of human Cot1 DNA(from a 1
mg/ml solution ; GibcoBRLR) and 32 µl of hybrisol VI
(Oncor R) denatured 5 min at 80°C and incubated 30
min at 37°C before deposition on the slide. The slides
were then incubated overnight at 37°C in a humidified
chamber and washed three times 5 min at 42°C in 50%
formamide, and in 2 × SSC at 42°C. After being rinsed in
4 × SSC at room temperature, the slides were incubated
for 30 min at 37°C in blocking solution (Roche Diagnos-
tics Meylan France). The digoxigenin was detected using
an anti-digoxigenin-rhodamin-labelled antibody (Appli-
gene OncorR) and the biotin with FITC labelled avidine
(Appligene OncorR).
The slides were washed with 4 × SSC for 10 min in a
shaker. After draining the excess liquid, DAPI was used as
counterstain and Vectashield R (Vector laboratories Inc.
Burlingame, CA 94010, USA) as antifading solution. Pic-
tures were acquired on a Zeiss epifluorescence microscope
using a tri-CCD camera and Vysis computer software
(Smart capture 2). Chromosome assignments were made
using reverse DAPI by reference to the GTG banded ideo-
grams of chicken proposed by Ladjali-Mohammed et al
[22].
The cytogenetic localization of the various BAC DNAs was
performed by two independent FISH runs. For each exper-
iment 50, and 25 cells were analyzed respectively. Except
for rare cases, four chromatids per cell showed a specific
signal and the percentage of triploid and tetraploid cells
present in the embryonic chicken fibroblast culture was
taken into account.
Human-chicken genomic comparisons
Syntenic conserved chromosome segments between
human and chicken were determined from Schmid et al
[23]. Human cancer genes localized in the syntenic areas
were selected from the "Atlas of Genetics and Cytogenetics
in Oncology and Hematology". http://www.infobio
gen.fr/services/chromcancer/. Their presence in the pre-
sumed chicken chromosome areas was investigated by
data processing using different web sites (NCBI:http://
www.ncbi.nlm.nih.gov, EMBL EBI : http://
www.ebi.ac.uk/embl/, infobiogène : http://www.infobio
gen.fr for human and NCBI, Wageningen university :
Maping of BAC2 on Gga1q14 (triploid metaphase)Figure 8
Maping of BAC2 on Gga1q14 (triploid metaphase).
Mapping of BAC sequences on chicken chromosome 3 and 5Figure 6
Mapping of BAC sequences on chicken chromosome 3 and 5.
Co-localisation and assymetrical duplication of areas identi-fied by BAC 50 (red) and 65 (green)Figure 7
Co-localisation and assymetrical duplication of areas identi-
fied by BAC 50 (red) and 65 (green).
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http://www.zod.wau.nl/vf/ for chicken) and by calcula-
tion from the physical to the cytogenetical localisation
using the relative position in the sequence and the " con-
sensus mid-points " of the markers reported in Schmid et
al [23].
Results
Isolation of BACs clones harbouring genomic DNA 
fragments flanking the viral/cellular junctions of MAV1-
related proviruses
From the libraries of lambda recombinant DNA prepared
with tumors 501D, 501 and 725 [5] we derived a total of
23 DNA fragments containing genomic sequences flank-
ing the junction fragments that were previously identified
in these three MAV-induced tumors. These fragments are
representative of MAV Integration Regions (MIRs) at the
chromosomic scale. Their size ranged from 800 bp to 4. 7
kb. Each of them was checked by Southern blot analysis
on chicken genomic DNA for the presence of repetitive
sequences (figure 1B,C). Only one of them was found to
contain repetitive sequences (figure 1B) and was dis-
carded. The 22 remaining clones were used as probes for
screening a chicken BAC (Bacterial artificial chromosome)
library which contain 60.000 clones arrayed in 96-well
plates and with an average insert sizes of 120–150 kb (fig-
ure 1A). The probes were pooled by groups of three or
four prior to hybridization. A total of 78 positive clones
were selected for further studies, the DNA of which was
digested with Not I and hybridized with the different
probes separately to verify that they indeed contained
MIRs (figure 1D,E).
Three different groups of BACs were isolated (figure 2)
with the probes originating from the three nephroblasto-
mas. Each group was tumor-specific. None of the probes
from one given tumor, hybridized with BACs correspond-
ing to another tumor (data not shown). Furthermore,
when all BACs from each group were radiolabeled and
used as probes on BACs from the two other groups, no
overlaping sequence could be found (data not shown).
These results indicated that no DNA fragment was com-
mon to the collection of 78 BACs. Interestingly probes 4
and 16 hybridized with several different BACs (4,7,8,10,
14,16) in the same group, and probes 81 and 62 hybrid-
ized with two different BACs (23.4 and 24.4) that belong
to another group. These results suggested that two integra-
tions sites of MAV were localized in the same DNA frag-
ments in tumor 725 and in tumor 501. However, they
correspond to different MIRs in the chicken genome.
In order to localize the various MIRs at a chromosomic
scale, we have performed FISH experiments using the var-
ious BACs as probes.
Chromosome localization of BACs
Eighteen BACs, containing sequences detected with the
different probes could be assigned on the chicken chro-
mosomes (figure 3). Although the distribution of MIRs on
macro and micro-chromosomes corresponded to the
expected theoretical value the number of MIRs mapped
Detection of CCN3 sequences in normal and tumor DNAFigure 9
Detection of CCN3 sequences in normal and tumor DNA. 
RNA species purified from normal kidney cells (N) and 
tumor cells (T) were labeled (see materials and methods) and 
used to probe BAC15 DNA that harbors the ccn3 gene. The 
DNA fragments detected with the RNA species expressed in 
tumor cells (panel B) confirm that ccn3 is overexpressed in 
the tumor context. As a control, the DNA fragments from 
BAC15 were hybridized with radiolabeled chicken ccn3 
cDNA. The DNAfragments which are detected correspond 
to exons encoding the ccn3 RNA species that are highly 
expressed in the tumor context (panel C).
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on chromosome Gga2 was twice as larger as the number
that would be expected from a random distribution.
Four BACS (2, 22, 83 and 100) were mapped on chromo-
some Gga1 (figure 4). Six BACs (15, 50, 64, 65, 85 and 97)
mapped on Gga 2 (figure 5). BAC 15 contains the ccn3
locus which was previously assigned to Gga2 [28]. Two
BACs (1 and 90) mapped on Gga5 and BACs 71 and 102
were maped on Gga 3 and 6 respectively (figure 6)
The precise identification of the micro-chromosomes that
gave a positive signal was not performed but co-hybridi-
zation experiments established that the four positive BACs
corresponded to loci which were localized on 4 different
microchromosomes (data not shown).
It is worth noting that the DNAs from 2 Bacs (22 and 100)
which were isolated with three different cellular probes
from tumor 501 (41, 57 and 51 respectively) co-localized
on Gga 1q11 (figure 4) and could not be separated on
interphasic nuclei. From these results, one could estimate
that the distance separating the sequences contained in
BACs 22 and 100 is smaller than a thousand kilobases.
Similarly DNA sequences from BACs 50 and 65 which
were detected by probes 10 and 18 co-localised on Gga
2q21 (figure 7). In that case, the analysis of asynchronus
replicative figures allowed us to establish that the corre-
sponding loci were distinct and probably contained in a
DNA segment of a few hundred kilobases. Most interest-
ingly, two BACs (1 and 90) isolated with probes from two
Differential expression of genes contained in positive BACsFigu  10
Differential expression of genes contained in positive BACs. The digested BACs DNAs were hybridized with labeled RNA spe-
cies isolated from either normal kidney cells (N) or tumor cells (T). Comparison of the hybridization patterns allowed to iden-
tify DNA fragments containing genes whose expression is either enhanced or abolished in tumors.
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different tumors (725 and 501) were assigned to Gga
5q23-25.
The strong signals obtained after hybridization of the
chicken BACs with other galliform chromosomes sug-
gested that the sequences of the MAV targets are relatively
well conserved throughout the galliform order. The chro-
mosome assigments were identical, with respect to karyo-
types evolution among these birds. As an example,
markers of Gga2 are scattered on two chromosomes in
Castreus wallishii (data not shown).
We have localized BAC2 which carries the chicken
AdamTS1 gene on GGA1q12-q14 region, most probably
in q14 (figure 8). The physical distance (fractional length
measurement or Flpter) for the Adam TS1 gene is 542. To
date, a series of 6 genes have been assigned on chicken
chromosome GGA1q12-q14: IFNAR2, IL10R, IFNAR1,
GART (q12-q13); SOD1; CRYAA q14 of which the human
heterologs lie on chromosome segment Hsa21q22.1-
q22.3. Excepted for CRYAA which segregated on Chromo-
some Mmu17, all these markers were found together in
the mouse on chromosome Mmu16 [23]. Human and
mouse AdamTS1 were respectively assigned on
HSA21q21.3 [32] and MMU16.
The assignment of ccn3 on Gga 2q34-36 was already
reported [28]. To date, a series of nine genes have been
assigned on chicken chromosome 2q: PRKDC (q24-25),
PENK, MOS, LYN (q26), CALB1 (q26), CA2, TRHR, MYC
and HSF1 of which the human homologs lie on chromo-
some segment 8q11-q24.1[23]. The localization of ccn3
on human 8q24 and chicken chromosome 2q34-36 rein-
forced the chromosomal homology between the two spe-
cies and suggested that the syntenic segment between the
two species could be extended up to avian 2q3. Further-
more, the mouse ccn3 gene maps to chromosome 15 [33]
in a region of conserved synteny with man including
TRHR, MYC and HSF1 [23].
The order of genes on the chicken map is still subject to
changes. Furthermore, based on detailed analyses on
other chicken chromosomes many rearrangements are
known to occurr within syntenic regions. However, with
the restriction regarding the order of the genes, the present
findings suggest that ccn3 and AdamTS1 belong to syn-
tenic groups well conserved between chicken, mouse and
man. These genes also constitute another example where
the synteny is better conserved between chicken and man
than between man and mouse.
ADAMTS1 sequences are overexpressed in MAV-induced 
nephroblastomas
The detection of ADAMTS1 locus as a MAV integration site
caught our attention because the ADAMTS1 protein
belongs to a family of proteases involved in angiogeneis
and tissue remodeling that are both required for tumor
progression [32]
In order to establish whether the BACs of interest indeed
contained genes differentially expressed in tumor sam-
ples, polyadenylated RNA species purified from normal
kidneys and nephroblastomas, were used to probe
digested BAC-DNAs.
As a control we first checked that hybridization performed
with these labeled RNA species permitted detection of the
ADAM TS1 is contained in the 6.2 kb DNA fragment from BAC2Figure 11
ADAM TS1 is contained in the 6.2 kb DNA fragment from 
BAC2. The nucleotide sequence of the mRNA species 
encoded by the 6.2 kb DNA fragment identified by differen-
tial hybridization of BAC2 with tumor and normal RNA spe-
cies is aligned with the human ADAM TS1 sequence.
                                                       10
cDNA    -----------------------------------------ATGGCCGATGTGGGAACCG
                                              :::::::::::::::::::
ADAMTS1 GGCAGGACCTCTGTGGTGCCAAGACATGTGATACTCTCGGGATGGCCGATGTGGGAACCG
              130       140       150       160       170       180
      20        30        40        50        60        70
cDNA    TTTGTGATCTAAACCGCAGTTGCTCTATCATAGAGGACGACGGCTTGCAGGCTGCCTTCA
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 TTTGTGATCTAAACCGCAGTTGCTCTATCATAGAGGACGACGGCTTGCAGGCTGCCTTCA
              190       200       210       220       230       240
      80        90       100       110       120       130
cDNA    CTACAGCCCACGAGCTAGGCCACGTGTTTAACATGCCTCATGACGATGCAAAGCAGTGTG
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 CTACAGCCCACGAGCTAGGCCACGTGTTTAACATGCCTCATGACGATGCAAAGCAGTGTG
              250       260       270       280       290       300
     140       150       160       170       180       190
cDNA    CTGGCATTAATGGAATAAGCCGGGATTTCCACATGATGGCATCCATGCTTTCCAACCTGG
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 CTGGCATTAATGGAATAAGCCGGGATTTCCACATGATGGCATCCATGCTTTCCAACCTGG
              310       320       330       340       350       360
     200       210       220       230       240       250
cDNA    ATCGCAGCCAGCCCTGGTCTCCATGTAGTGCCTACATGATTACAACATTTTTGGATAACG
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 ATCGCAGCCAGCCCTGGTCTCCATGTAGTGCCTACATGATTACAACATTTTTGGATAACG
              370       380       390       400       410       420
     260       270       280       290       300       310
cDNA    GTCATGGTGAGTGTTTGTTGGACAAGCCCCACAGACCAATCCAGCTTCCTTCTGACCTGC
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 GTCATGGTGAGTGTTTGTTGGACAAGCCCCACAGACCAATCCAGCTTCCTTCTGACCTGC
              430       440       450       460       470       480
     320       330       340       350       360       370
cDNA    CCGGCACGCTGTATGATGCCAACAGACAGTGCCAGTTCACTTTTGGAGATGAATCCAAGC
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 CCGGCACGCTGTATGATGCCAACAGACAGTGCCAGTTCACTTTTGGAGATGAATCCAAGC
              490       500       510       520       530       540
     380       390       400       410       420       430
cDNA    ACTGCCCTGATGCAGCCAGTACGTGCACAACTCTGTGGTGTACCGGCACTTCGGGAGGAC
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 ACTGCCCTGATGCAGCCAGTACGTGCACAACTCTGTGGTGTACCGGCACTTCGGGAGGAC
              550       560       570       580       590       600
     440       450       460       470       480       490
cDNA    TGCTCGTCTGCCAAACCAAACACTTCCCTTGGGCGGATGGTACCAGTTGTGGGGAAGGGA
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 TGCTCGTCTGCCAAACCAAACACTTCCCTTGGGCGGATGGTACCAGTTGTGGGGAAGGGA
              610       620       630       640       650       660
     500       510       520       530       540       550
cDNA    AATGGTGCATGAATGGCAAGTGTGTGAATAAGACTGAGAAGAAGCATTATGATACCCCAG
        ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
ADAMTS1 AATGGTGCATGAATGGCAAGTGTGTGAATAAGACTGAGAAGAAGCATTATGATACCCCAG
              670       680       690       700       710       720
     560       570       580       590       600       610
cDNA    TGCATGGCAGCTGGGGGTCCTGGGGAGCATGGGGAGAATGCTCCCGGAGCTGCGGCGGCG
        :::::::::::
ADAMTS1 TGCATGGCAGC-------------------------------------------------
              730
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DNA fragments of BAC15 which contained the CCN3
gene [28] known to be overexpressed in all MAV-induced
nephroblastomas. Indeed, the size of the DNA fragments
whose detection was highly increased after hybridization
with tumor-derived RNA species corresponded to the size
of the genomic CCN3 Hind III fragments that was previ-
ously drawn from the characterization of the ccn3 chicken
locus (figure 9 and ref1).
Typical results obtained with a series different BACs are
shown in figure 10. Various BACs contained DNA
sequences encoding RNA species that were either
decreased or increased in tumors, or both.
As a first step in our identification of MIRs, we focused on
BAC2 because it contained sequences mapping in the
vicinity of ADAMTS1, and it provided a simple differential
hybridization pattern. Two DNA fragments (6.2 kb and
3.2 kb) encoded abundant RNA species in the tumor sam-
ples, whereas a low molecular weight fragment encoded
sequences that were slightly reduced in tumors. Only the
6.2 kb and 3.2 kb fragments could be subcloned. When
used as probes on chicken DNA, the 3.2 kb fragment was
found to contain repetitive sequences and could not be
used for further studies. The 6.2 kb fragment of BAC2
could be used as a probe to check that it was indeed
strongly detected by RNA from the tumor samples (data
not shown). To identify sequences that were expressed
from this 6.2 kb DNA fragment, the cloned insert was
used as a probe to screen a chicken spleen cDNA library.
Sequencing of two positive cDNA clones indicated that
they were sharing 100% identity with part of the human
ADAMTS1 coding sequence (figure 11). These results indi-
cated that the DNA locus containing the chicken
ADAMTS1 gene, was a MAV integration site and suggested
that disregulation of ADAMTS1 might be involved in the
development of MAV-induced nephroblastomas. North-
ern blotting of RNA species isolated from normal kidneys
and four different MAV-induced nephroblastomas indeed
established that ADAMTS1 was overexpressed in the 4
Detection of ADAMTS1 expression in normal kidney and nephroblastoma tissuesFigure 12
Detection of ADAMTS1 expression in normal kidney and nephroblastoma tissues. RNA samples 3,4, 5 and 20 were prepared 
from MAV1-induced nephroblastomas collected 18 weeks after injection of MAV1 and RNA samples 8,12, and 12 were pre-
pared from normal kidney of 18 week old chicken. Electrophoresis and Northern blotting were performed as described in the 
text. The resulting blot was hybridized under stringent conditions with radiolabeled cDNA corresponding to the chicken 
ADAMTS1 sequence. Samples of glyceraldehyde 3 phosphate dehydrogenase RNA were used as quantitation standard.
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MAV-induced nephroblastomas as compared to normal
tissue (figure 12).
Discussion
The studies that we have performed during the past dec-
ade have allowed us to identify viral sequences responsi-
ble for the very high efficiency and restricted pathogenic
potentential of MAV1-(N) [29-31]. We also established
that MAV-induced nephroblastomas were polyclonal
tumors [4] that constituted a unique model of the pediat-
ric Wilms tumor [1].
The analysis of genomic libraries prepared from MAV1-
induced tumors representing three different stages in
tumor progression established that the MAV proviral
genomes contained in the DNA of the tumor cells were
not integrated in common sites. However, the relatively
small size of the DNA insert transduced by the recom-
binant lambda phages, did not permit to exclude the pos-
sibility that MAV proviral genomes were inserted in
common regions at the chromosome scale.
In order to determine whether MAV-induced rearrange-
ments of the host genome were common to the three
chicken nephroblastoma tumours that represented
increasing developmental stages [5], we have isolated and
characterized 78 BACs containing the normal DNA frag-
ments corresponding to the insertional sites of MAV in the
genome of these tumor cells. The molecular analysis of
these BACs did not permit us to identify any common
integration sites, but one, among the three different
tumors.
It is well known that selective pressures likely occured dur-
ing tumor progression and that the integration sites that
we might identify at the late stages could be associated
with events that led to tumor establishment. Therefore the
lack of a common integration site, at a scale of 150 kb,
probably reflected the various developmental stages and
phenotypes of the tumors. On the other hand, our results
suggested that preferential MAV integration sites might be
conserved in the developed tumors, since independent
junction fragments corresponding to different proviral
genomes cloned from a given tumor, were hybridizing
with the same BACs. These results suggested that the dis-
tribution of MAV integration sites in the tumors might not
represent initial events but rather reflect the complex
chromosome rearrangements that occur during tumor
progression.
The use of BACs to perform a FISH analysis of the MAV
integration sites permitted us to gain a better insight into
the distribution of integration sites in the various tumors
that we analyzed. In spite of the polyclonal nature of the
nephroblastomas, a rather simple profile was obtained.
The chicken genome is composed of 34 chromosomes,
among which are 9 macrochromosomes and 25 micro-
chromosomes. The MAV integration sites were found to
be equally distributed between the micro and macrochro-
mosomes that stained positive. However, these sites were
not distributed randomly. Instead, the number of MAV
integration site on chromosome 2 was much higher than
expected and 3 integration sites were detected on this
chromosome by two independent BACs. These finding
suggested that during the establishment and progression
of nephroblastomas, the maintenance of chromosome 2
alterations were preferentially selected. The results
obtained by FISH confirmed that MAV proviral genomes
were integrated in a limited number of sites, as previously
predicted by junction fragment analysis [4] and pulse field
electrophoresis [1].
During the preparation of this manuscript, Pajer et al.
reported the use of inverse PCR and LTR-RACE to identify
nephroblastoma-associated loci (Nals) in MAV2-induced
avian nephroblastomas (Pajer, personal communication
and manuscript in press). In order to compare the posi-
tion of MAV insertion sites identified by FISH and PCR,
we have calculated the physical localization of the Nals on
each corresponding chromosome and found a fairly good
match between the two sets of results (See additional file
1: Compilation of cytogenetic data obtained from FISH
analysis). In both studies, MAV integration sites were
found to be mainly distributed among chromosomes 1
and 2. Of particular interest was the identification of hot
spots for proviral sequences at 1q1, and 2q2. Whether
these sites represent preferential MAV integration sites or
regions that contain genes required for tumor develop-
ment remains an open question.
Two different types of information could be drawn from
these observations: i) the distribution of MIRS and Nals
points to chromosome regions that frequently harbour
proviral MAV sequences in tumors; these regions likely
contain genes that are important for tumor development;
and ii) the reduced number of MAV integration sites that
are maintained during tumor progression points to genes
that are probably important at later stages, and the com-
parison of MAV integration sites in early and late tumors
might help to distinguish between genes involved in the
establishment and in the maintenance of the tumor state.
Based on the relatively well conserved synteny betwen
man and chicken it was also possible to predict the nature
of potential genes of interest. The use of normal and
tumor RNAs as probes to identify BAC fragments that con-
tain genes that are differentially expressed in normal and
tumor tissue (figure 10) also provided critical information
that could be used as another clue to assign potential
genes to MAV insertion loci.
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MAV integration sites were identified by FISH analysis
(BACs 50, 65, 64, 97, 15) on Chromosome 2. Among the
potential genes of interest contained in these areas Plag1
(8q12 in human), and twist (7p21) are target in 6% and
4% of MAV2-induced tumors (Pajer et al. In ress). Both
encode transcription factors that are thought to play a role
in tumorigenesis, LRCC (Leiomyomatosis and Renal Cell
Cancer, 1q42-44 in human) is associated with papilloma
renal cancer, while WTSL (Wilms tumor suppressor locus,
7p14-13 in human) is a potential suppressor gene whose
alteration appears to be involved in normal kidney devel-
opment and nephroblastoma. The CCN3/NOV gene
(8q24-1 in human) which is a target for both MAV1 and
MAV2-induced tumors (see below) is also localized on
chromosome 2. The Gga 2 p3-2 zone represents a hot spot
for MAV integration. Three BACs (85, 50 65) were
mapped in this area. Bac 85 is a little more distal than the
3 others. BACs 50 and 65 are very close to each other but
distinct. It is worth noting that Nal 2–28 (Pajer et al. in
press) which include the twist gene overlaps with BACs 50
and 65. Our investigations also pointed out WTLS (at
7p11p15 in human) as a locus of interest for BACs 50 or
65.
Within the cytogenetic region Gga1q1 several genes of
interest were potentially detected by FISH with BAC 22
and BAC 100. Among them, the cyclin-dependent kinase
inhibitor 1B (CDKN 1B, 12p13 in human) and the N-ras
oncogene (1p13 in human). In the same area, the data
obtained by Pajer et al (in press) pointed to the POU2,
OTF1, Oct1 transcription factors (1q22-3 in human). The
localisation of BAC83 at Gga 1qter suggests as a potential
target BIRC3 (Hsa 11q21) a candidate oncogene which is
highly expressed in normal kidney and was reported to
inhibit apoptosis.
At Gga3q24, the Wilms tumour 1 associated protein
(WTAP, 6q25-27 in human) is a potential gene of interest
for the region that is detected by two independant probes
on BAC 71.
Two MAV1 insertion sites maped at 5q23-25 on the
chicken genome. The human syntenic fragment (14q21-
33), GPH (gephyrin at 14q23.3), TRAF3 (TNF receptor
associated factor 3, at 14q32-33) and TGFβ3 (Transform-
ing growth factor 3, at 14q24).
BACs 1 and 90 which maped at Gga 5 q23-25, contain
MAV integration sites that were identified in two tumors
representing different developmental stages. Both
mapped very close to each other but did not co-localized
since Bac1 is more proximal than Bac 90. The human syn-
tenic fragment (14q21-33) contains several genes
involved in kidney development and tumorigenesis.
Among them, RCC2 (renal cell carcinoma 2, at 14q22-ter)
is a locus which is lost in sporadic, non papillary renal cell
carcinomas and oncocitomas. GPH (Gephyrin at
14q23.3) is a cytoplasmic, peripheral protein that anchors
Gly-R. Although it is widely expressed, it is especially pre-
dominantly expressed in kidney. TRAF3 (TNF receptor
associated factor 3 at 14q32-33) encodes an adapter pro-
tein that recruits other signaling molecules to the ligand-
bound TNF family receptor. A gradient of TRAF3 is
detected along the nephron, with progressive expression
from proximal tubule to the collecting duct. TGFB3 is a
well know transforming growth factor.
The region defined by BAC1 and 90 also corresponded to
Nal 5–13 (Pajer et al. In press). Because these integration
sites were identified in tumors representing different
developmental stages, this area corresponded to a com-
mon integration region whose alteration is conserved dur-
ing tumor progression, therefore suggesting that the
gene(s) encoded by this portion of genome might be crit-
ical for nephroblastoma development and (or) tumor
progression.
In addition to this situation, the two other integration
sites identified in the most developed tumor by BACs 15
and 2 corresponded respectively to ccn3/nov (8q24.1 in
human) and AdamTS1 (21q23.1 in human), two genes
whose involvement in angiogenesis, matrix remodeling
and tumorigenesis is well documented [7,19-27]. The
ccn3 gene was previously mapped on chicken chromo-
some 2q34-36 [28]. Although the present study, and the
results of Pajer et al. indicated that ccn3 is not a common
integration site for MAV, this gene was identified as a MAV
target in both studies. However, the MAV2-induced
tumors analyzed by Pajer et al. did not show any increase
in ccn3 expression.
Since both the MAV1- and the MAV2-induced nephrob-
lastomas that we analyzed showed elevated levels of ccn3
expression [1], these conflicting observations result from
either the route of injection, the time frame for injection,
the different nature of the viral strains or host differences.
The MAV2 (O) strain that was used in our previous studies
was molecularly cloned and sequenced [2]. It induced
20% nephroblastomas, as opposed to 100% efficiciency
of the MAV1(N) strain. In both cases, nephroblastomas
were induced after intraveinous injection of 14 day-old
embryos or intraperitoneal injection of day old chicken
[1]. Since we have established that blastemal cells under-
going epithelial differentiation are the targets for MAV1,
the time frame and route of injection may be critical.
Indeed, the blastemal cells express high levels of ccn3
(Cherel et al. manuscript in preparation). Therefore, the
elevated levels of ccn3 expression detected in all MAV-
induced nephroblastomas might result from the expan-
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sion of blastemal cells that are transformed at a well
defined stage of differentiation upon MAV1 infection.
Hybridization of BACs containing MAV1-integration sites
with labeled mRNAs isolated from normal kidney tissue
and nephroblastomas also permitted us to perform an
analysis of the genes that are proximal to MAV integration
sites and that are differentially expressed in normal and
tumor condition. Among the different genes that were
uncovered in this study, the ADAMTS1 gene was of poten-
tial interest. The ADAMTS1 protein is a matricellular pro-
teinase known to participate in the late stages of
tumorigenesis. Forty-five percent of newborn ADAMTS1
null mice died, probably as a result of kidney malforma-
tion that becomes apparent at birth [34].
Comparison of the expression pattern of CCN3 and
ADAMTS1 shows striking similarities. In both cases over-
expression of the protein is detected in all tumors tested,
while the MAV proviral sequences are detected only once
in the vicinity of these genes. These observations suggest
that MAV -induced nephroblastoma occurs via a multistep
process that involves a cascade of proteins acting along a
common signaling pathway. Direct or indirect alteration
of any step could result from MAV integration within or in
the vicinity of critical genes whose increased expression
would eventually be required for tumor progression. The
identification of TGFβ 3 locus as a target for MAV integra-
tion in two independent tumors (501 and 725) is in favor
of such an hypothesis. The role of TGFβ 1 in expression of
CCN genes expression has been widely documented and
the antagonistic activity of TGFβ 1 and TGFβ 3 has been
shown to be critical in several instances. The activation of
TGFβ3 expression by MAV might therefore result in an
increased expression of CCN3 in tumors, similar to that
observed upon integration of MAV within the ccn3 gene
itself. Interestingly, tumor 725 which is the most devel-
oped is the only one in which integration of MAV occured
in three gene loci whose alterations would have cummu-
lative effects. A less developed tumor such as 501 only
shows integration in the vicinity of TGFβ 3 and the early
developed tumor does not show any of them.
In summary, our present study suggests that the develop-
ment of nephroblastoma from an initial diffuse tumor
phenotype (501D) to a well developed compact tumor
(725) is accompanied by the selection of MAV integration
sites in chromosome loci where genes involved in kidney
differentiation are localized. The alteration of any of these
genes by MAV integration at early stages of blastemal cell
differentiation, would trigger the tumorigenic process.
The multiplicity of potential genetic and cellular targets
would provide support to the very high efficiency of
MAV1 (N) which can induce 100% nephroblastomas
within a 8-week period of time post injection. It will be
interesting to determine whether the phenotypic variabil-
ity of the MAV-induced nephroblastomas compares to the
Wilms' tumors situation, and if the various subtypes of
tumors result from different sequences of genes altera-
tions.
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